Pointers to Cancer Prognosis

Pointers to Cancer Prognosis

EnglishPaperback / softback
Kluwer Academic Publishers
EAN: 9780898388763
On order
Delivery on Friday, 30. of August 2024
CZK 1,317
Common price CZK 1,463
Discount 10%
pc
Do you want this product today?
Oxford Bookshop Praha Korunní
not available
Librairie Francophone Praha Štěpánská
not available
Oxford Bookshop Ostrava
not available
Oxford Bookshop Olomouc
not available
Oxford Bookshop Plzeň
not available
Oxford Bookshop Brno
not available
Oxford Bookshop Hradec Králové
not available
Oxford Bookshop České Budějovice
not available

Detailed information

The last 30 years have seen little improvement in the age-adjusted mortality rates for most common types of cancer, and until we develop more effective and less damaging treatment modalities for these tumours, selection of each patient's treatment must depend on prognostic pointers. These lead to a calculated trade­ off between our estimate of likely benefit to the patient, as against cost in terms of quality of life. But changes have occurred recently in our understanding of the traditional prognostic pointers used for selecting such individualised treatment. First, it is increasingly recognised that the stage at which a tumour presents is more related to the chromo logical age of the tumour (how far it has progressed before diagnosis) than to its biological characteristics. While advanced chronological age of the tumour may predict a greater likelihood of early death, only biological criteria can predict the tumour growth rate, the likelihood of prolonged survival, the likely course of the disease after the first recurrence or the likehood of response to systemic therapy. Second, there is increasing use of failure analysis in relating the clinical and biological characteristics of tumours to their response to standard treatments. In the past, the relationship was interpreted mainly in terms of survival rate, but the site and timing of first recurrence and the pattern and timing of subsequent spread provide a better assessment of the control possible from local or systemic therapy.
EAN 9780898388763
ISBN 0898388767
Binding Paperback / softback
Publisher Kluwer Academic Publishers
Publication date February 28, 1987
Pages 368
Language English
Dimensions 235 x 155
Country United States
Readership Professional & Scholarly
Illustrations XII, 368 p.
Editors Stoll, B.A.
Edition Softcover reprint of the original 1st ed. 1987
Series Developments in Oncology